Medicare and Commercial Plans Fail to Get New Generics to Patients
Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays
AAM: Medicare Part D plans slow to adopt generics
The First (Price) Cut Is the Steepest
